Until there are more regulations on delta-8 tetrahydrocannabinol (∆8-THC), poison centers (PCs) will continue to get calls. That's according to a new study suggesting delta-8 THC exposure is lower in states where such products are banned and where cannabis use is legal, reported Marijuana Moment.
"Our findings showed a statistically significant lower rate of ∆8-THC exposures reported to PCs [poison centers] among states where medical or recreational cannabis use was legal than states where cannabis use was illegal," according to the researchers. "This is likely attributable, in part, to less market competition from ∆9-THC products in states where their use was illegal, and that ∆8-THC was likely being used as a substitute for ∆9-THC."
Published in the Journal of Medical Toxicology, the study took a closer look at exposures involving delta-8 THC reported to PCs nationwide, including variation among states and regions. The study analyzed data from National Poison Data System data for delta-8 exposures from Jan. 1, 2021, through Dec. 31, 2022.
That said, the states in the U.S. South, where recreational marijuana can't be legally purchased from licensed retailers, accounted for the majority of all exposures, or 69.8% out of a total of 4,925 exposures reported to PCs.
"The rate of ∆8-THC exposures reported to US PCs increased by 79% from 2021 to 2022, with the US South accounting for more than two-thirds of exposures," concluded the researchers from Nationwide Children's Hospital, the Ohio State University College of Medicine's pediatrics department, the University of Colorado School of Medicine, the Central Ohio Poison Center and the organization Child Injury Prevention Alliance.
在對delta-8四氫大麻酚(∆8-THC)有更多的監管規定出台之前,毒物中心(PCs)將繼續接到電話。根據一項新研究,禁止銷售此類產品和大麻使用合法的州中,∆8-THC接觸的風險較低。
根據研究人員稱:「我們的研究結果顯示,在醫療或娛樂大麻使用合法的州,報告給毒物中心的∆8-THC接觸率明顯較低,而在大麻使用非法的州,這一比例較高。這很可能部分歸因於非法州市場上∆9-THC產品的競爭較少,以及∆8-THC很可能作爲∆9-THC的替代品使用。」
這項發表在《醫學毒理學雜誌》上的研究更仔細地調查了全國各地向毒物中心報告的涉及delta-8-THC的接觸情況,包括各州和地區之間的差異。該研究分析了2021年1月1日至2022年12月31日期間國家毒物數據系統中關於delta-8接觸的數據。
然而,在美國南部這些不能在合法經銷商處合法購買娛樂大麻的州,佔據了所有報告給毒物中心的接觸案例的大多數,即69.8%的4,925例接觸案例。
研究人員來自全美兒童醫院、俄亥俄州立大學醫學院兒科學部、科羅拉多大學醫學院、中部俄亥俄毒物中心以及兒童傷害防護聯盟。他們得出結論:「從2021年到2022年,報告給美國毒物中心的∆8-THC接觸案例增長了79%,其中美國南部佔據了接觸案例的三分之二以上。」